Cytokinetics CYTK Debt Repayments
Debt Repayments at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's debt repayments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's debt repayments?
- Cytokinetics (CYTK) reported debt repayments of $2.74M in Q1 2026.
- How has Cytokinetics's debt repayments changed year-over-year?
- Cytokinetics's debt repayments increased by 2.0% year-over-year, from $2.68M to $2.74M.
- What does debt repayments mean?
- Cash used to pay down debt principal.
- How do you interpret debt repayments?
- Higher repayments indicate active debt reduction and improved balance sheet health, while lower repayments may signal a focus on cash preservation or refinancing.
- How does debt repayments compare across companies?
- Common for companies with structured debt; peers often time repayments to coincide with cash inflows from operations or financing events.